Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Sucralfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cosette Pharma`s Generics Sucralfate Receives Approval in US
    Cosette Pharma`s Generics Sucralfate Receives Approval in US

    13 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217126

    FDA
    13 Nov 2024
    Share Share
    Strides receives USFDA approval for Sucralfate OralSuspension, 1gm/10 mL
    Strides receives USFDA approval for Sucralfate OralSuspension, 1gm/10 mL

    23 May 2024

    // PRESS RELEASE

    https://strides.com/pdf/pressrelease/2024/StridesSEIntimation_22May_24.pdf

    PRESS RELEASE
    23 May 2024
    Share Share
    Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 Ml
    Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 Ml

    22 May 2024

    // PRESS RELEASE

    https://strides.com/pdf/pressrelease/2024/StridesSEIntimation_22May_24.pdf

    PRESS RELEASE
    22 May 2024
    Share Share
    Abon Pharma Generic Sucralfate Receives Approval in the U.S
    Abon Pharma Generic Sucralfate Receives Approval in the U.S

    21 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216726

    FDA
    21 Mar 2024
    Share Share
    Enforcement Report - Week of October 25, 2023
    Enforcement Report - Week of October 25, 2023

    25 Oct 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-25-2023-66768.pdf

    FDA
    25 Oct 2023
    Share Share
    VistaPharm LLC Issues Voluntary Nationwide Recall of Sucralfate Oral Suspension, 1g/10mL Due to Microbial Contamination Identified as Bacillus Cereus
    VistaPharm LLC Issues Voluntary Nationwide Recall of Sucralfate Oral Suspension, 1g/10mL Due to Microbial Contamination Identified as Bacillus Cereus

    22 Sep 2023

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vistapharm-llc-issues-voluntary-nationwide-recall-sucralfate-oral-suspension-1g10ml-due-microbial

    FDA
    22 Sep 2023
    Share Share